Based on 5 analysts giving stock ratings to Health Catalyst Inc in the past month.
In the current month, HCAT has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. HCAT average Analyst price target in the last month is 1.767.
Based on analysts' estimates, HCAT EPS is projected to reach -0.043 in FY2026Q4, following reported EPS of 0.537 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.54, while Health Catalyst IncHCAT's earnings per share (EPS) for the previous quarter was USD -0.55. EPS for the next quarter is expected at USD -0.04.